I could speculate as to the reason why Sanofi didn't take it up, but I would be lying if I tried to put a theory forward and say it was that.
Well part of the announcement was the hiring of another staff member in Europe which I presume could help see us through these processes. If you were TK and were presented with the opportunity to have this tria/test run in 3 hospitals, would you say "Thanks but no thanks, we'll just run with one hospital for now"? It would probably be a worse look on the company and people would say how can you not handle that capacity?
I see you're not holding unless your sentiment is not updated, but either way, GLTAH. I'll leave the rest of the posting to more experienced heads than me.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Builds European Market Presence
Ann: ResApp Builds European Market Presence, page-42
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 222 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)